CONMED CORPORATION Share Repurchase Authorization
CONMED CORPORATION (CNMD) had Share Repurchase Authorization of $150.00 million as of 2025-10-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Equity
srt:StockRepurchaseProgramAuthorizedAmount1 · last filed 2026-02-17
- 2025-10-31: Stock Repurchase Program Authorized Amount1 $150.00M.
- 2024-12-31: Stock Repurchase Program Authorized Amount1 $200.00M.
| Period end | Stock Repurchase Program Authorized Amount1 |
|---|---|
| 2025-10-31 | $150.00M 10-K · filed 2026-02-17 |
| 2024-12-31 | $200.00M 10-K · filed 2025-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |